An endothelin antagonist for resistant hypertension

Lancet. 2010 Feb 20;375(9715):636; author reply 636-7. doi: 10.1016/S0140-6736(10)60262-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory
  • Drug Administration Schedule
  • Endothelin Receptor Antagonists*
  • Humans
  • Hypertension / drug therapy*
  • Phenylpropionates / pharmacology
  • Phenylpropionates / therapeutic use*
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Time Factors

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Phenylpropionates
  • Pyrimidines
  • darusentan